Medical Weight Loss

Tirzepatide Injection

Starting at$376 / month

OversightClinician reviewed

FulfillmentU.S. licensed pharmacies

Physician consultation
Shipping included
Supplies & syringes

Clinicianreviewed

Freeshipping

Cancelanytime

Medical Weight Loss

A once-weekly injection that turns down appetite signaling and drives steady, real weight loss.

Choose your medication

Select treatment cycle

Subscription required

Total due now

$375.95

$375.95 per month · 1 Month

Prescription items are subject to physician review before dispensing. Once you check out, you'll get member portal access to complete a medical intake form. A licensed physician reviews it, and if you're approved, your medication ships. Your provider sets the exact dose during that review.

Understand the protocol

Tirzepatide Injection

01What it does

Turns down hunger at the source, not through willpower.

A dual GIP/GLP-1 agonist that slows gastric emptying, dampens appetite signaling in the brain and sharpens insulin sensitivity — so portions shrink naturally and glucose holds steadier between meals.

02Who it's for

For weight that refuses to budge.

Adults with a BMI of 27 or above, patients who've stalled despite disciplined nutrition and training, and anyone managing insulin resistance or metabolic syndrome under clinician oversight.

03What results look like

A realistic timeline.

Cravings typically ease within the first few weeks. As the dose titrates, most patients lose 1–2 lb weekly, reaching 15–22% total body weight loss with better metabolic labs over a full course.

Weeks 1–4

Appetite quiets

Food noise drops and portions shrink on their own. Early weight change is modest and mostly water.

Weeks 5–12

Steady loss begins

Most patients see a consistent weekly trend as dosing is titrated to what your body tolerates.

Months 4–6

Composition shifts

Waist, energy and labs move together when protein and training hold. The scale is no longer the only signal.

Months 6+

Maintenance

Dose is often reduced and held at the lowest level that keeps the result stable.

Timelines are typical ranges reported in clinical use and by Argo patients. Individual results vary with dose, adherence, baseline health and lifestyle.

Weekly

Subcutaneous injection

15–22%

Typical weight reduction

12 wks

To meaningful change